Koers Cantabio Pharmaceuticals Inc. Other OTC
Aandelen
CTBO
US13808X2036
Biotechnologie & Medisch Onderzoek
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 2,36 mln. 2,17 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -1 mln. -921K | Nettowinst (verlies) 2018 | -2 mln. -1,84 mln. | EV/omzet 2017 | - |
Nettoschuld 2017 | 337K 310K | Nettoschuld 2018 | 1,1 mln. 1,01 mln. | EV/omzet 2018 | - |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-
| Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 29,99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gergely Tóth
FOU | Founder | 51 | 06-02-12 |
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22-05-15 |
Max Zhu
BRD | Director/Board Member | 42 | 01-01-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22-05-15 |
Gergely Tóth
FOU | Founder | 51 | 06-02-12 |
Max Zhu
BRD | Director/Board Member | 42 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+54,05% | 63,85 mld. | |
-2,02% | 41,83 mld. | |
+40,01% | 40,47 mld. | |
-10,22% | 27,17 mld. | |
+13,42% | 26,52 mld. | |
-21,60% | 18,69 mld. | |
+2,89% | 12,73 mld. | |
+22,40% | 12,11 mld. | |
+27,49% | 12,07 mld. |